RTsafe announces first use of its PseudoPatient patient-specific quality assurance process by NSH CyberKnife Cancer Center, Dubai, UAE

RTsafe announces first use of its PseudoPatient patient-specific quality assurance process by NSH CyberKnife Cancer Center, Dubai, UAE

ATHENS, Greece, July 4, 2023 RTsafe, (www.rt-safe.com) the leading provider of quality assurance products and services in stereotactic radiosurgery, announces that UAE’s NSH CyberKnife Cancer Center at Neuro Spinal Hospital, Dubai (NSH – www.nshdubai.com) has conducted its first simulated therapy for multiple brain cavernomas using PseudoPatient, RTsafe’s patient-specific quality assurance process. This represents the first […]

RTsafe facilitates ISRS certification

  Athens, June 9, 2023   Radiosurgery departments aiming to achieve ISRS (International Stereotactic Radiosurgery Society) certification can now streamline their preparation process with the help of RTsafe. As a leading provider of End-to-End Stereotactic Radiosurgery products and services, RTsafe has launched a dedicated consulting service to help applicants achieve the stringent quality assurance and patient […]

RTsafe announces first use of its PseudoPatient patient-specific quality assurance process by Fundación Instituto Valenciano de Oncología (IVO)

  Athens, Greece, February 13, 2023   RTsafe, the leading provider of quality assurance products and services in stereotactic radiosurgery, announces that Spain’s Fundación Instituto Valenciano de Oncología (IVO) has conducted its first simulated therapy for brain metastases using PseudoPatient, RTsafe’s patient-specific quality assurance process that comprises an anatomically faithful model of each patient’s head aligned to […]

×
«
ΕΣΠΑ Banner